Friday, October 5, 2007

Combination Therapy Reverses Effects Of Portal Hypertension In Rats (Science Daily)

A combined treatment with rapamycin and Gleevec might reverse the effects of portal hypertension in patients with chronic liver disease. Portal hypertension is a serious complication of chronic liver disease, and a leading cause of liver transplantation and mortality. It develops when a blockage in the blood flow through the liver causes the body to develop new blood vessels to develop (through ...

Read More...

[Source: Yahoo! News Search Results for liver disease help]

No comments: